- Report
- March 2025
- 200 Pages
Global
From €2266EUR$2,490USD£1,943GBP
- Report
- October 2024
- 237 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- October 2024
- 244 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- March 2024
- 30 Pages
Global
From €2503EUR$2,750USD£2,146GBP
- Report
- February 2023
- 220 Pages
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- October 2024
- 90 Pages
Global
From €3500EUR$4,120USD£3,106GBP
Zontivity is a market of cardiovascular drugs used to reduce the risk of heart attack and stroke in adults with a history of heart disease. It is a type of antiplatelet drug, which works by preventing the formation of blood clots in the arteries. Zontivity is used in combination with other medications, such as aspirin, to reduce the risk of cardiovascular events. It is also used to reduce the risk of recurrent stroke in patients who have had a stroke or transient ischemic attack. Zontivity is available in both oral and injectable forms.
The Zontivity market is highly competitive, with several major pharmaceutical companies offering products. These include Merck, Pfizer, AstraZeneca, and Bristol-Myers Squibb. Other companies in the market include Daiichi Sankyo, Sanofi, and Boehringer Ingelheim. Show Less Read more